These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6328991)
1. Cerebral blood flow in patients with congestive heart failure treated with captopril. Paulson OB; Jarden JO; Godtfredsen J; Vorstrup S Am J Med; 1984 May; 76(5B):91-5. PubMed ID: 6328991 [TBL] [Abstract][Full Text] [Related]
2. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Rajagopalan B; Raine AE; Cooper R; Ledingham JG Am J Med; 1984 May; 76(5B):86-90. PubMed ID: 6328990 [TBL] [Abstract][Full Text] [Related]
3. Effect of captopril on the cerebral circulation in chronic heart failure. Paulson OB; Jarden JO; Vorstrup S; Holm S; Godtfredsen J Eur J Clin Invest; 1986 Apr; 16(2):124-32. PubMed ID: 3089807 [TBL] [Abstract][Full Text] [Related]
4. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats. Barry DI; Paulson OB; Jarden JO; Juhler M; Graham DI; Strandgaard S Am J Med; 1984 May; 76(5B):79-85. PubMed ID: 6328989 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and regional blood flow response to captopril in congestive heart failure. Levine TB; Olivari MT; Cohn JN Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361 [TBL] [Abstract][Full Text] [Related]
8. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure. Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977 [TBL] [Abstract][Full Text] [Related]
9. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786 [TBL] [Abstract][Full Text] [Related]
10. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753 [TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril. Jarden JO; Barry DI; Juhler M; Graham DI; Strandgaard S; Paulson OB J Hypertens; 1984 Dec; 2(6):599-604. PubMed ID: 6098609 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Awan NA; Evenson MK; Needham KE; Win A; Mason DT Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100 [TBL] [Abstract][Full Text] [Related]
13. Effect of captopril on renal function in patients with congestive heart failure. Pierpont GL; Francis GS; Cohn JN Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555 [TBL] [Abstract][Full Text] [Related]
14. Acute renal effects of captopril in patients with congestive heart failure. Ribstein J; Mimran A J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554 [TBL] [Abstract][Full Text] [Related]
15. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Levine TB; Franciosa JA; Cohn JN Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102 [No Abstract] [Full Text] [Related]
16. [Hemodynamic effects of the acute administration of captopril in refractory chronic congestive heart failure. Study of 13 patients and review of the literature]. Dall'Aglio V; Rellini G; Charmet P; Cassin M; Variola A; Menin A; Manfroni A; Meneguzzo N; Bazzi A G Ital Cardiol; 1983 Sep; 13(9):153-9. PubMed ID: 6363191 [TBL] [Abstract][Full Text] [Related]
17. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906 [TBL] [Abstract][Full Text] [Related]
18. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure. Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564 [TBL] [Abstract][Full Text] [Related]
19. Improvement of chronic congestive heart-failure by oral captopril. Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679 [TBL] [Abstract][Full Text] [Related]
20. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril. Townend JN; Doran J; Lote CJ; Davies MK Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]